Systematic review and meta-analysis of randomised controlled clinical trial evidence refutes relationship between pharmacotherapy with angiotensin-receptor blockers and an increased risk of cancer.

CONCLUSIONS: The results of our meta-analysis focusing only on high evidence levels and study designs (RCTs) did not reveal any relationship between pharmacotherapy with an ARB and an increased risk for cancer in general.
PMID: 31060961 [PubMed - as supplied by publisher]

Source: European Journal of Internal Medicine - May 2, 2019 Category: Internal Medicine Authors: Datzmann T, Fuchs S, Andree D, Hohenstein B, Schmitt J, Schindler C Tags: Eur J Intern Med Source Type: research